Pentwater Capital Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,184,021
| Closed | -$140M | – | 383 |
|
|
2021
Q1 | $140M | Buy |
1,184,021
+6,021
| +0.5% | +$713K | 1.34% | 17 |
|
|
2020
Q4 | $139M | Buy |
1,178,000
+713,872
| +154% | +$84.3M | 1.68% | 13 |
|
|
2020
Q3 | $51.6M | Buy |
464,128
+64,558
| +16% | +$7.17M | 0.67% | 26 |
|
|
2020
Q2 | $40.8M | Buy |
399,570
+236,798
| +145% | +$24.2M | 0.73% | 19 |
|
|
2020
Q1 | $17.6M | Buy |
162,772
+54,623
| +51% | +$5.9M | 0.29% | 29 |
|
|
2019
Q4 | $12.6M | Buy |
108,149
+24,659
| +30% | +$2.87M | 0.21% | 34 |
|
|
2019
Q3 | $9.56M | Buy |
+83,490
| New | +$9.56M | 0.15% | 34 |
|